Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| high prostate |
|
A Randomized Trial of Lycopene Supplementation in Tobago Men with with High Prostate Cancer Risk. Clareann H. Bunker, Alicia C. McDonald, prostate cancer prevention trials in low- to moderately high-. risk men. Significantly High Prostate Cancer Cure Rate With Brachytherapy Eighty-two of the Seattle patients were characterized as being high risk. That subset had stage T2b or higher prostate cancer, Gleason scores of 7 or higher Oncology (General Cancer): High prostate levels I may be a sign of it! It can also be a sign of a big prostate. But with this fast increase in his PSA(?) level you must suspect a prostate cancer. Toward a better understanding of the comparatively high prostate This study assesses whether comparatively high prostate cancer incidence rates among white men in Utah represent higher rates among members of the Church of A small chimeric promoter for high prostate-specific transgene for high and prostate-specific transgene expression from adenoviral vectors. METHODS. .. small promoter that facilitates high prostate-specific IngentaConnect High prostate cancer mortality in Norway: Influence In conclusion, the high rates of prostate cancer mortality in Norway could not be explained by information transfer from the CR to the COD Registry. A novel monoclonal antibody 107-1A4 with high prostate specificity Monoclonal antibodies with high specificity for prostate tissue are of interest for prostate cancer research and treatment. Reactivity and specificity of a New US Study Links Obesity with High Prostate Cancer Mortality A new US Study has found that obese men are more likely to die of prostate cancer within five Prostate High Dose Rate (HDR) Brachytherapy Prostate high dose rate brachytherapy is perhaps the most accurate way to precisely target the prostate gland with a high dose of radiation. Biochemical disease-free survival in patients with a high prostate patients with a high prostate-specific. antigen level (20â“100 ng/mL) and. clinically localized prostate cancer. after radical prostatectomy Gene marker signals high prostate cancer risk- msnbc.com Scientists have identified a common genetic marker that signals a 60 percent heightened risk of prostate cancer in men who carry it, and it may help explain |
| high prostate |
|
home remedy of enlarged prostate laproscopic prostate surgery prostate cancer cryotherapy natural prostate treatments |